Eli Lilly shareholder plans $405M share sale

Lilly Endowment, Inc. also lists earlier Lilly share sales on August 13, August 19, October 7, October 14 and October 15, 2026.

Rhea-AI Filing Summary

Lilly Endowment, Inc., identified as a shareholder, gave notice of its intended sale of 295,000 Eli Lilly and Company common shares, with an aggregate market value of $405,241,500. J.P. Morgan Securities LLC is identified as the broker, and October 30, 2026, as the approximate sale date.

The notice also lists five earlier sales by Lilly Endowment from August 13 through October 15, 2026. Peter A. Buck, Vice President for Investments & Grants Administration, signed the notice.

Key Figures

Shares intended for sale: 295,000 shares Aggregate market value: $405,241,500 Issuer shares outstanding: 940,745,031 shares +5 more

8 metrics

Shares intended for sale 295,000 shares Eli Lilly and Company common shares; approximate sale date October 30, 2026

Aggregate market value $405,241,500 Intended sale

Issuer shares outstanding 940,745,031 shares Figure listed with the intended sale

Prior shares sold 122 shares August 13, 2026

Prior shares sold 302,403 shares August 19, 2026

Prior shares sold 28,357 shares October 7, 2026

Prior shares sold 271,643 shares October 14, 2026

Prior shares sold 305,000 shares October 15, 2026

Key Terms

Rule 144, person, aggregated

3 terms

Rule 144 regulatory

"paragraph (e) of Rule 144"

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

person regulatory

"See the definition of "person" in paragraph (a) of Rule 144"

aggregated regulatory

"sales required by paragraph (e) of Rule 144 to be aggregated"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many LLY shares does Lilly Endowment plan to sell?

Lilly Endowment, Inc. gave notice of an intended sale of 295,000 Eli Lilly and Company common shares, with an aggregate market value of $405,241,500. J.P. Morgan Securities LLC is named as broker, and October 30, 2026, is the approximate sale date.

What earlier LLY share sales did Lilly Endowment report?

The notice lists sales of 122 shares on August 13, 2026; 302,403 shares on August 19, 2026; 28,357 shares on October 7, 2026; 271,643 shares on October 14, 2026; and 305,000 shares on October 15, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 10/30/2026 - 02:56 PM EDT Accepted by SEC EDGAR 10/30/2026 - 02:55 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0000316011
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	ELI LILLY AND COMPANY
SEC File Number	001-06351
Address of Issuer	LILLY CORPORATE CTR DROP CODE 1094 INDIANAPOLIS INDIANA 46285
Phone	317-276-2000
Name of Person for Whose Account the Securities are To Be Sold	LILLY ENDOWMENT, INC.
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Shareholder

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	J.P. Morgan Securities LLC 383 Madison Avenue New York NY 10179	295000	405241500	940745031	10/30/2026	NYSE, NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	02/10/1948	Gift	J.K. Lilly Sr. Trust		01/21/1937	38400000		N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Lilly Endowment Inc. 2801 North Meridian Street Indianapolis IN 46208	Eli Lilly and Company Common Stock	08/13/2026	122	151280
Lilly Endowment Inc. 2801 North Meridian Street Indianapolis IN 46208	Eli Lilly and Company Common Stock	08/19/2026	302403	385708676.04
Lilly Endowment Inc. 2801 North Meridian Street Indianapolis IN 46208	Eli Lilly and Company Common Stock	10/07/2026	28357	34117815.29
Lilly Endowment Inc. 2801 North Meridian Street Indianapolis IN 46208	Eli Lilly and Company Common Stock	10/14/2026	271643	328823634.19
Lilly Endowment Inc. 2801 North Meridian Street Indianapolis IN 46208	Eli Lilly and Company Common Stock	10/15/2026	305000	385561998.50

144: Remarks and Signature

Remarks
Date of Notice	10/30/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Peter A. Buck, Vice President for Investments & Grants Administration
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)